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Abstract: The applicability and safety of bacteriophage Delta as a potential anti-Pseudomonas aerugi-
nosa agent belonging to genus Bruynoghevirus (family Podoviridae) was characterised. Phage Delta
belongs to the species Pseudomonas virus PaP3, which has been described as a temperate, with cos
sites at the end of the genome. The phage Delta possesses a genome of 45,970 bp that encodes tRNA
for proline (Pro), aspartic acid (Asp) and asparagine (Asn) and does not encode any known protein
involved in lysogeny formation or persistence. Analysis showed that phage Delta has 182 bp direct
terminal repeats at the end of genome and lysogeny was confirmed, neither upon infection at low
nor at high multiplicity of infection (MOI). The turbid plaques that appear on certain host lawns
can result from bacteriophage insensitive mutants that occur with higher frequency (10−4). In silico
analysis showed that the genome of Delta phage does not encode any known bacterial toxin or
virulence factor, determinants of antibiotic resistance and known human allergens. Based on the
broad host range and high lytic activity against planktonic and biofilm cells, phage Delta represents
a promising candidate for phage therapy.
Keywords: Pseudomonas phage Delta; Pseudomonas virus PaP3; genome ends; bacteriophage in-
sensitive mutants (BIM); bacterial virulence factors; antibiotic resistance genes; human allergens;
therapeutic phage selection
1. Introduction
Bacteriophages are potential therapeutic agents against multidrug and pandrug resis-
tant bacteria which are used throughout the world [1]. One of the major problems of phage
application as antibacterial agents in the past was the incomprehension of bacteriophage
biology [2]. The first prerequisite that must be fulfilled before consideration of a phage
as a therapy candidate is its obligatorily lytic nature and good lytic efficacy. Temperate
phages can integrate their genome into bacterial DNA, and by an imprecise excision during
induction (i.e., initiation of a lytic cycle), they can excise bacterial DNA and transfer it
into a new bacterial host through specialised transduction [3]. Some of these genes can
contribute to the virulence or antibiotic resistance of infected bacteria. Both obligatorily
lytic and temperate phages can be responsible for generalised transduction, which occurs
during phage DNA packaging into procapsids. Sometimes bacterial DNA is packaged
into viral particles, and frequency of this phenomenon primarily depends on the DNA
packaging mechanism, which is the most prominent in phages that use the head-full mech-
anism [4]. In this context, careful phage selection should prevent the transfer of genes
encoding virulence factors, human/animal allergens or genes responsible for bacterial
resistance to antibiotics [5–8]. Some phages encode proteins involved in their own life cycle,
which also act as eukaryotic toxins or allergens; the best-known example is Vibrio phage
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CTXphi, whose zonula occludens toxin (Zot) is involved in phage extrusion [9]. So far,
many phages have been described, and their genomes were sequenced, including phages
of Pseudomonas aeruginosa. However, even today, beside a lot of information available,
crucial characteristics (e.g., phage temperate or obligatorily lytic nature) are not taken into
account during selection for in vivo studies and clinical trials.
Pseudomonas virus PaP3 (Viruses; Duplodnaviria; Heunggongvirae; Uroviricota; Cau-
doviricetes; Caudovirales; Podoviridae; Bruynoghevirus) has been described originally by Tan
et al. [10], and beside the type strain Pseudomonas phage PaP3, additional strains have
been described later. These phages share phenotypic characteristics: morphotype C1, with
short tail; broad lytic activity against various strains of P. aeruginosa and high in vitro lytic
efficacy. It is interesting to point out that a phage belonging to genus the Bruynoghevirus
is a part of a commercial preparation for human application (e.g., Intesti-bacteriophage,
Georgia) [11]. However, some properties important for the phage therapeutic application
have not yet been described, including involvement in production of toxins, allergens or
antibiotic resistance factors. On the other hand, some published data are controversial; for
instance, Pseudomonas virus PaP3 is described as a temperate phage with cohesive ends
(cos) [10], while Pseudomonas virus Luz24, was described as an obligatorily lytic phage with
direct terminal repeats (DTR), lacking the cos site [12].
The study aimed to examine genome of phage Delta, a new strain of species Pseu-
domonas virus PaP3, and other properties important from the aspect of phage therapy, by
determining the phage integrative properties, genome ends and potential presence of
genes for bacterial toxins, antibiotic resistance and known human allergens. Thus, here we
elucidated phage Delta safety for therapeutical application.
2. Materials and Methods
2.1. Phage Preparation
The previously isolated Pseudomonas phage Delta [13] was multiplied using original
host Pseudomonas aeruginosa strain PA-4U, precipitated in PEG6000 and NaCl, and puri-
fied in CsCl by density ultracentrifugation, as described previously [13,14]. The phage
suspension was dialyzed and further treated with DNase and RNase. The purified phage
suspension was used for all experiments.
2.2. DNA Sequencing
DNA was isolated from virions using standard phenol-chloroform procedure [15].
The isolated DNA was treated with RNase and re-precipitated. Whole genome sequencing
of phages was performed using Illumina technology, while de novo assembly of sequenced
fragments was carried out by CLC Genomics Workbench 6.5 software and Mira 4.
2.3. Phage Delta Genome Analysis
Open reading frames (ORF) in phage Delta genome were predicted using Gene-
markS [16] and MyRast [17]. The genomic DNA was compared using BLASTN algorithm
with other related strains and species of genus Bruynoghevirus, as well as from other related
genera (Krylovvirus, Vicosavirus and Bjornvirus). Phages of the same species share >95%
DNA similarity (identity × query coverage) and phage exemplars belonging to the same
species are considered phage strains [18].
The whole genome sequences of bacteriophages were obtained from GenBank and
used for phylogenetic analysis (listed in Table 1). Phage phylogeny was examined using
MUSCLE alignment and phylogenetic tree was constructed using MEGAX [19]. The major
capsid protein and terminase amino-acid sequences were compared among the phages
using ClustalW alignment and Maximum Likelihood method with Kimura 2-parameter
model and bootstrap value 1000 [20].
The presence of tRNA genes in the genomes were predicted for phage Delta and
(re)checked for other related phages using ARAGORN (http://mbio-serv2.mbioekol.lu.
se/ARAGORN/, accessed on 6 June 2016) [21] and tRNAScanSE Search Server (http://
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lowelab.ucsc.edu/tRNAscan-SE/, accessed on 16 May 2016) [22]. BLASTN algorithm was
used to determine PaP3 related prophage existence in sequenced genomes of Pseudomonas
strains available in GenBank. The lifestyle of the phages was predicted using the PHACTS
algorithm (http://www.phantome.org/PHACTS/, accessed on 18 July 2016) [23].
2.4. Lysogeny Formation
To examine possibility of phage Delta integration into bacterial DNA, phages and
sensitive P. aeruginosa PAO1 strain were incubated for 24 h at 37 ◦C at MOI 0.1 and 10. The
mixture was then plated on a Luria-Bertani medium to obtain colonies of survived bacterial
cells. Several colonies were picked up, transferred onto new medium and subsequently
their DNA was isolated using GeneJET Genomic DNA Purification Kit (Thermo Fisher
Scientific, Vilnius, Lithuania). The extracted DNA was digested using FastDigest endonu-
clease SmaI (Thermo Fisher Scientific, Inc., Waltham, MA, USA), which cannot cut phage
Delta DNA but can cut bacterial DNA, generating many small-sized fragments. In parallel,
DNA of non-infected bacteria was used as a control of enzyme activity and absence of
phage Delta DNA in the bacterial genome, while phage DNA was used as a negative
control of enzyme activity (i.e., control of phage DNA integrity after SmaI treatment). DNA
fragments were visualised on 0.7% agarose gels with ethidium bromide under UV light
and documented (BioDoc Analyse, Biometra, Germany).
2.5. Bacteriophage Insensitive Mutants (BIM)
The incidence of phage Delta insensitive mutants of P. aeruginosa was determined
using a modified method by O’Flynn et al. (2006) [24]. Two bacterial strains were used for
the experiment: PA-4U, a urine isolate UB-5296 and ear-infection strain OB-7025 [13]. To
obtain MOI = 10, 1 × 1010 CFUmL−1 of bacteria and 1 × 1011 PFUmL−1 of bacteriophage
were added. Based on the Poisson distribution, MOI of 10 gives 100% infection in a culture,
so only BIM can survive. The mixture of phage and bacteria was incubated at 37 ◦C for
15 min and then various volumes were poured over solid LB medium. The plates were
incubated at 37 ◦C, and the number of survived cells was determined by counting colonies
after 24 and 48 h. The mean colony numbers and standard deviations were calculated
from three independent experiments with three replicates. The frequency of occurrence of
mutants was calculated as the ratio of the number of grown colonies and the initial number
of bacteria per milliliter. Phage resistance and absence of (pro)phage genome in cells were
additionally performed.
2.6. Determination of Phage Genome Ends
The presence of cos sites at the ends of phage Delta genomic DNA was examined
by the coherence of the two terminal restriction fragments [25]. For this purpose, DNA
was restricted by BamHI that gives a few well distinctive bands. The restricted DNA was
heated at 75 ◦C 15 min and then cooled either slowly at room temperature or rapidly on ice.
The slow cooling conditions lead to annealing of cohesive ends, visible on an agarose gel
as an appearance of a larger size band, with loose or fainting of two smaller sized bands.
Under fast cooling conditions, the two terminal bands do not have time to anneal, giving
no change of the original RFLP pattern. The products were analysed by 1.0% agarose gel
electrophoresis detected with ethidium bromide under UV light and documented (BioDoc
Analyse, Biometra, Göttingen, Germany).
2.7. Potential Virulence Factors
Potential virulence factors encoded by phages were examined by BLASTP algorithm
against a virulence factor database (VFDB, http://www.mgc.ac.cn/VFs/main.htm, ac-
cessed on 17 July 2016) [26]. Hits with more than 70% coverage and 30% identity were
considered as positive results or if E < 10−3.
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2.8. Antibiotic Resistance Genes
Potential antibiotic resistance genes in the genome of Pseudomonas virus PaP3 were
examined by BLASTP against the resistance gene database, with setup value >10% identity
and E < 10−3 (https://card.mcmaster.ca/analyze/blast, accessed in 5 July 2016) [27].
2.9. Potential Allergens
The phage proteins were analysed to identify potential human allergenic proteins,
using tools available at http://www.allergenonline.com (accessed on 15 July 2016) from
the Food Allergy Research [28]. For the full-length alignments by BLASTP a possible
cross-reactivity was considered if E < 10−3. An additional method, using a sliding window
of 80 amino acid segments of each protein, was also carried out to confirm significance.
The best identities of phage proteins and allergens greater than 35% and E < 10−3 were
considered significant [29].
3. Results and Discussion
Phage Delta morphology corresponds to other strains of the species Pseudomonas virus
PaP3 with the head diameter of approx. 60 nm and morphotype C1 [25]. The genome
nucleotide sequence was deposited in the GenBank database under accession number
MG432151, and it consists of 45,970 bp with GC% 52.2 (Table 1). Three tRNA were detected:
tRNA- proline (Pro), asparagine (Asn) and aspartic acid (Asp), as in other strains of
Pseudomonas virus PaP3, with an exception of PaP3 phage that encodes tRNA for tyrosine
(Tyr) in addition. The genome encodes 69 proteins and approximately one third of genes
are in opposite orientation in comparison to the rest of the genome. The genome comprises
early genes, genes for DNA synthesis/replication, virion assembly and host lysis but lacks
integrase, repressor and known genes involved in prophage persistence.
The phylogenetic analyses based on amino-acid sequences of major head protein
(Figure 1A) and terminase (Figure 1B) showed relations of phage Delta to members of the
genus Bruynoghevirus from the family Podoviridae, but also to genera Krylovvirus, Vicosavirus
and Bjornvirus. Analyses of DNA similarity of phage Delta sequence confirmed that this
phage belongs to the species Pseudomonas virus Pap3, and that there are nine different
strains in total, along with phage Delta, isolated throughout the world that belong to this
species (Table 1).
The bacteriophage Delta has broad lytic activity against many P. aeruginosa strains
(72.7% from a culture collection) [13] and has prominent lytic activity against both plank-
tonic and biofilm cells [14]. Even though the phage is a promising candidate for phage
therapy, its close relative, phage PaP3, was proven to be temperate with genome containing
cos ends. This characteristic is not desirable from the aspect of phage application in therapy,
therefore the phage Delta was further examined.
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Figure 1. Phylogenetic relationships of phage Delta with other related phages (members of Bruynoghevirus—green,
Krylovvirus—red, Vicosavirus—orange and Bjornvirus—blue) and a prophage of P. tolassii, based on amino-acid sequences
of major coat protein (A) and terminase (B). The evolutionary history based on protein sequences was inferred using the
Maximum Likelihood method and JTT matrix-based model. Initial trees for the heuristic search were obtained automatically
by applying Neighbor-Joining and BioNJ algorithms to a matrix of pairwise distances estimated using a JTT model, and
then selecting the topology with superior log likelihood value. Evolutionary analyses were conducted in MEGA X [18] and
the percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are
shown next to the branches [19]. Vibrio phage VPp1 was used as an outlier.
3.1. Is Bacteriophage Delta Temperate or Obligatorily Lytic Phage?
With the exception of PaP3, lysogeny formation was not confirmed neither for other
strains of species Pseudomonas virus PaP3, nor for other members of the genus Bruynoghevirus.
For PaP3 phage, a sequence in tRNA-Pro was postulated as an att site (GGTCG-
TAGGTTCGAATCCTAC), and it is in accordance with the fact that tRNAs are generally
considered an integration site into the bacterial genome [47]. This 21-mer sequence is
present in all strains of the species Pseudomonas virus PaP3 and phage phiCHU, while
almost all other members of the genus Bruynoghevirus have one A→G transition in the
sequence (Table 1). Even though this difference can be a reason why lysogeny have not
been proven in these phages, enzymes involved in recombination/integration usually are
not sensitive to the point mutations [48,49].
The phages of peripherally related genera Krylovvirus, Bjornvirus and Vicosavirus also
lack this postulated 21-mer att sequence, although Krylovvirus encode tRNA in contrast with
other two genera. Only for Vicosavirus lysogeny formation was confirmed, and it seems
that att site is different. Namely, when phage Delta genome, or genome of other members
of genus Bruynoghevirus are compared to Pseudomonas aeruginosa group (taxid:136841) or
Pseudomonas (taxid:287) by BLASTN algorithm in silico, no significant similarities were
detected, i.e., P. aeruginosa available genomes do not contain sequences similar to these
phages (the results are not shown). Among the sequenced genomes of various Pseudomonas
species, only one prophage of Pseudomonas tolaasii 2192T showed some similarity to phages
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of genus Bruynoghevirus (31.8–36.2%), and significant similarity with members of genus
Vicosavirus (72.1–89.3%) (Table 1 and Figure 1). The prophage in P. tolaasii genome, related
to Bruynoghevirus, neither encode tRNAs nor integrates in the proximity of bacterial tRNA.
For instance, prophage integration occurs at a tRNA gene for phages carrying Lambda
and P4-like integrases, although they do not encode any tRNA, but only small parts of the
gene [50]. However, Bailly-Bechet et al. (2007) [51] indicate that tRNA presence in phage
genome is not primarily because of integration but found a significant association between
tRNA distribution and codon usage, as phage tRNA codons are simultaneously highly used
by the phage genes, being rare in the host genome. They even found that obligatorily lytic
phages contain more tRNAs than temperate ones. Just as a comparison, the well-known
obligatorily lytic T4 also encodes tRNA [52], without ability to form lysogeny. Thus, the
presence of tRNA genes in Bruynoghevirus not necessarily indicates their temperate nature.
The alignment of postulated P. tolaasii 2192T prophage ends indicated 42-mer att
site with sequence GATGCAGATGGGCGTAATGCTCAACAAGAACCGCGAGGCTGC
(Table S1), which is different from postulated att site of PaP3 related phages, and can be
found only in Vicosavirus members (Table 1). Accordingly, even if the phages from the
genus Bruynoghevirus integrate into the host DNA, the integration site is different than
for Vicosavirus.
Furthermore, it seems that some phages of genus Bruynoghevirus contain genes po-
tentially involved in lysogeny formation. For instance, a protein conserved region from
SPFH superfamily (stomatin, prohibitin, flotillin and HflK/C) can be detected in some
related viruses, including the prophage of P. tolaasii (Table 1). This protein is frequently
annotated as „transposase fusion protein“. The similar protein HflK/C (High frequency
of lysogenization) plays a role in the decision making between lysogenic and lytic cycle
during Lambda phage infection, antagonising activity of FtsH ATPase/protease, that in E.
coli is involved in degradation of Lambda phage cII transcriptional activator, responsible
for lysogenisation [53,54]. The role of this protein is still not clear, since some phages
that are characterised as obligatorily lytic encode it, such as Pseudomonas phage KPP10,
PAK-P3, P3-CHA, CHA_P1 and PAK_P5 (Myoviridae), which were successfully used in a
cystic fibrosis mice model [55–57]. Thus, phages that encode this protein may be temper-
ate, but its presence in genome is not necessary confirmation of phage temperate nature.
Furthermore, the analysis showed that the protein with the conserved SPFH sequence is
absent in all strains of Pseudomonas virus PaP3, in phages phiCHU, Luz24, phiBB-PAA2,
Epa2 (genus Bruynoghevirus), tf (genus Krylovvirus) and Bjorn (genus Bjornvirus) (Table 1).
Even the lack of phage encoded integration enzymes in other PaP3 related phages
does not, however, undoubtedly confirm their obligatorily lytic nature, as prophages can
be formed by the activity of corresponding host enzymes [58]. For type strain PaP3, it has
been previously demonstrated that upon P. aeruginosa PAO1 infection, the phage genome
can be detected as an uncut band by PstI endonuclease in bacterial genomic DNA.
Using the SmaI enzyme, which cannot cut phage Delta genome, we have not confirmed
phage genome in bacterial DNA by RFLP upon infection of PAO1 strain (Figure 2II). The
absence of the phage DNA band confirmed a lack of its integration or extrachromosomal
presence in PAO1, both after infection with low (MOI = 0.1) or high number of virions
(MOI = 10). The two different MOIs were used, as it was confirmed that phage lambda, a
model for temperate phages, increases the frequency of lysogeny at higher MOI [59]. A
study of global transcriptomic analysis of P. aeruginosa PAO1 after infection with PaP3 at
MOI = 10 indicate lytic cycle, according to the gene expression and the one-step growth
curve, that reach a plateau after 80 min. with burst size approx. 30 [60], resembling to
a lytic cycle. Alemayehu et al. (2015) examining phage strain MR299-1 indicated that a
previous study calls into question the temperate nature of PaP3 [12], since no site-specific
recombinase is encoded up- or downstream of the attP site, and immunity or reactivation
of the prophage was not demonstrated.
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Figure 2. Determination of Pseudomonas phage Delta properties and lifestyle: (I) PAO 1 genomic DNA (A, D and F) was
treated with SmaI (B) generating numerous fragments of small size; phage Delta DNA was not cut by SmaI (C); after PAO1
infection at MOI = 0.1 phage Delta genome was not detected in PAO1 genome (E), and similar was confirmed when PAO1
was infected at MOI = 10; (II) phage Delta DNA cut by BamHI show no change of restriction pattern after fast and slow
cooling, indicating absence of cos site; (III) DNA sequence of phage Delta showed elevation of reads typical for direct
terminal repeats; (IV) PHACTS algorithm showed that phage Delta is obligatorily lytic, with high confidence; (V) uncut
and SmaI-cut BIM genome showed absence of phage DNA and thus lysogeny; (VI) lysis of sensitive P. aeruginosa lawn by
phage Delta (a) and absence of lysis of BIM (b).
The application of PHACTS showed that all strains of species Pseudomonas virus PaP3
are obligatorily lytic, and the findings are confident for strains Delta (Figure 2V) and MR299-
2, but also for some other species of the genus Bruynoghevirus (Table 1). Similar pertains to
Krylovvirus and Bjornvirus, but Vicosavirus members are characterised as temperate (phage
UVF-P2 with high confidence). This additionally contributes to the obligatorily lytic nature
of Bruynoghevirus members, including phage Delta.
The turbid plaques produced by members of Bruynoghevirus on lawn of certain strains
cannot be simply explained by lysogeny formation. To elucidate this phenomenon, the
frequency of BIM was determined (Table 2). For original host PA-4U, the frequency of
mutant appearance was of order of magnitude 10−7, and for heterologous strains UB-6259
and OB-7025 frequencies were 10−6 and 10−4, respectively. The frequency of BIM was not
significantly changed after prolonged incubation. Since phage Delta form turbid plaques on
OB-7025 lawn, high frequency of BIM can partially provide an explanation for incomplete
lysis and faint plaques formation. The results indicate necessity to examine all host-phage
system to determine BIM frequency and to apply measures to decrease BIM frequency (by
using phage cocktails, combining phages and antibiotics etc).
Table 2. Frequencies of phage Delta insensitive mutant appearance of various strains.
BIM Frequency
Bacterial Host after 24 h after 48 h
PA-4U 3.30 × 10−7 ± 3.12 × 10−7 5.38 × 10−7 ± 5.56 × 10−8
UB-2596 2.36 × 10−6 ± 2.74 × 10−7 5.67 × 10−6 ± 1.67 × 10−6
OB-7025 7.95 × 10−4 ± 3.24 × 10−5 9.62 × 10−4 ± 4.12 × 10−5
Taking into account the above considerations, it is clear that there is no evidence that
strains of the species Pseudomonas virus Pap3 are temperate. Even if these phages are
temperate, their lysogeny is extremely unstable or integration is very rare.
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3.2. Is Pseudomonas phage PaP3 Prone to Generalised Transduction?
There are several types of phage termini: cohesive ends (5′- or 3′-single-strand ex-
tensions), circularly permuted direct terminal repeats, short or long exact direct terminal
repeats (DTR), terminal host DNA sequences or covalently bound terminal proteins. A
particular termini type is a result of a phage packaging strategy: 5′cos (e.g., Lambda phage),
3′cos (e.g., phage HK97), headful with a pac site (e.g., phage P1), headful without a pac
site (e.g., phage T4), DTR (e.g., phage T7) and host fragment at genome ends (e.g., phage
Mu) [25,61]. The bacteriophages that pack DNA by means of headful mechanism can
more frequently form defective virions, carrying parts of bacterial DNA, being prone to
generalised transduction [61,62]. This is not a desirable property for a phage intended for
therapy, since phages can transfer genes involved in bacterial virulence. Experiments with
phage Delta genomic DNA restriction pattern with BamHI showed no difference if samples
heated to 75 ◦C and then cooled quickly or slowly (Figure 2III), indicating the absence of
cos site. A 20-mer sequence postulated as a cos in PaP3 (5′-GCCGGCCCCTTTCCGCGTTA-
3′) [10] is present in most phage genomes that encode tRNA-Pro (Table 1), identical or
with one base changed. The analysis of the phage Delta genome sequence did not confirm
cos genome ends. Still, it revealed presence of 182 bp long DTR in the genome assembly
(Figure 2IV), which is obviously as twice as the average sequence coverage [62].
It is believed that mechanism of packaging and type of termini can be successfully
predicted from amino-acid sequence of large terminase subunits, which is quite conserved
among the most tailed-phage proteins [63]. Previous analyses of phage LUZ24 and PaP3
terminases are strongly related to the terminase of phage P22, which catalyses the head-
ful packaging, leading to both terminal redundancy and circular permutations [12,64].
However, some studies showed that terminase amino-acid sequence is not very reliable
in determination of packaging mechanism [65], which is confirmed for Luz24, as well as
phage Delta, that both have long direct terminal repeats (182 and 184 bp, respectively).
Summarising our results on genome ends examination, it is clear that phage Delta has a
packaging mechanism similar to phage T7, being less prone to generalised transduction
than phages with a headful packaging strategy. Finally, even if some phage Delta related
phages have cos, they also rarely mediate in horizontal transfer by generalised transduction
as phages with DTRs [66].
3.3. Does the Phage Delta Genome Encode Undesirable Proteins?
The results of phage protein in silico examination, carried out to find genes for po-
tential virulence factors, antibiotic resistance proteins and allergens, are presented in
Supplementary Materials.
Only one protein encoded by members of Pseudomonas virus PaP3 showed some
similarity with a bacterial virulence factors—Dot/Icm type IV secretion system effector
SidK of Legionella pneumophila subsp. pneumophila, but below cut-off E value. In the phages,
this protein is a small terminase subunit and has no conserved domains similar to the
virulence factor. Thus, the phages do not encode known bacterial virulence factors.
Analysis of known antibiotic resistance genes showed that almost all members of
genus Bruynoghevirus possess a gene similar to B3 class of beta lactamase, i.e., metallo-beta
lactamase found in Massilia oculi. Similarly, members of Vicosavirus also encode a protein
similar to class A beta lactamase precursor RCP found in Rhodopseudomonas capsulata.
However, the observed similarities are not significant, indicating that phages do not carry
known antibiotic resistance genes.
It is well known that phages do not cause allergic reactions after application, but since
their structural proteins are antigenic [67,68], the potential production of IgE should not
be neglected. The full-length BLASTP alignments and 80-mer sliding method showed
similarity of PaP3, phiCHU and UFV-P2 prroteins to 30 kDa salivary gland allergen variant
2 of Aedes aegypti. In addition, ORF 54 of phage PaP4 is significantly similar to collagen
alpha-2(I) chain isoform X1 of Salmo salar, and ORF 53 of phage tf is significantly similar
to high molecular weight glutenin subunit 10 of Triticum aestivum. According to the
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FAO/WHO 2001 experts and the Codex Alimentarius Commission (2003), a >35% identity
to an allergen over of any segment of 80 or more amino acids indicates possible cross-
reactivity. Even though phages are generally safe for application [69,70], if these phages are
intended for therapy, further evaluation of IgE reactivity or clinical cross-reactivity may be
warranted to test for these potential allergens. In potential clinical trials, all these phages
should be used with precautions in individuals allergic to corresponding antigens.
The results indicate that phage Delta proteins show no significant similarity to known
bacterial virulence factors, determinants of P. aeruginosa resistance to conventional antibi-
otics and allergens.
4. Conclusions
For most Bruynoghevirus members, including phage Delta, there is no evidence of
lysogeny formation, and DNA is packaged by the T7 model, indicating lower generalised
transduction capacity. The genome of the Delta phage does not encode known virulence
factors, antibiotic resistance determinants and allergens. These data, along with high lytic
efficacy and broad activity against various strains of P. aeruginosa recommend this phage as
a potent anti-Pseudomonas agent. Some shortfalls, such us high frequency of BIM can be
overcome by phage cocktail preparation, combination with antibiotics etc. If such thorough
analysis of a phage does not confirm undesirable properties, for the therapeutic phages
should be applied „presumption of innocence—everyone is considered innocent until
proven guilty“, i.e., a phage that fulfils criteria for application is considered safe for therapy
until proven otherwise.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/v13101965/s1, Table S1: Predicted PaP3 related prophage in genome of P. tolaasii 2192T
using various tools for prophage detection and manually predicted, Table S2: Potential virulence
factors, antibiotic resistance related proteins and allergens encoded by phage Delta and other related
(pro)phages.
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